About ZAGO-Zentrum für ambulante gynäkologische Onkologie
Clinical Trials at ZAGO-Zentrum für ambulante gynäkologische Onkologie
During the past decade, ZAGO-Zentrum für ambulante gynäkologische Onkologie conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "ZAGO-Zentrum für ambulante gynäkologische Onkologie"
#1 collaborator was "AGO Breast Study Group e.V." with 1 trials as a collaborator, "Clovis Oncology, Inc." with 1 trials as a collaborator, "Eli Lilly and Company" with 1 trials as a collaborator, "Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest" with 1 trials as a collaborator and "Novartis Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at ZAGO-Zentrum für ambulante gynäkologische Onkologie
According to Clinical.Site data, the most researched conditions in "ZAGO-Zentrum für ambulante gynäkologische Onkologie" are
"Advanced Breast Cancer" (1 trials), "Breast Cancer" (1 trials), "Breast Cancer Female" (1 trials), "Breast Neoplasm Female" (1 trials) and "Breast Neoplasms" (1 trials). Many other conditions were trialed in "ZAGO-Zentrum für ambulante gynäkologische Onkologie" in a lesser frequency.
Clinical Trials Intervention Types at ZAGO-Zentrum für ambulante gynäkologische Onkologie
Most popular intervention types in "ZAGO-Zentrum für ambulante gynäkologische Onkologie" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Abemaciclib + Aromatase Inhibitor" (1 trials), "Abemaciclib + Fulvestrant" (1 trials), "Placebos" (1 trials), "Ribociclib" (1 trials) and "Rucaparib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at ZAGO-Zentrum für ambulante gynäkologische Onkologie
The vast majority of trials in "ZAGO-Zentrum für ambulante gynäkologische Onkologie" are
3 trials for "Female" genders.
Clinical Trials Status at ZAGO-Zentrum für ambulante gynäkologische Onkologie
Currently, there are NaN active trials in "ZAGO-Zentrum für ambulante gynäkologische Onkologie".
undefined are not yet recruiting,
2 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in ZAGO-Zentrum für ambulante gynäkologische Onkologie,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in ZAGO-Zentrum für ambulante gynäkologische Onkologie, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".